Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00208065Phase 4Completed
A Phase 4 trial of almotriptan in migraine, sponsored by Clinvest Research. Started May 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00208065.